Background and Objectives: The beneficial effect of blood transfusion on kidney graft survival requires the presence of leukocytes in the transfusate, but a minimal dose has not been defined, nor has the role of individual leukocyte subsets been investigated. In the Netherlands, a standard pre-transplant blood transfusion consists of a buffy coat (BC)-depleted red blood cell concentrate (RBCC) containing a maximum of 1.2×109 residual leukocytes per unit. However, leukocyte subset composition is not standardized. Materials and Methods: Using FACS analysis, this study compared the residual leukocyte composition of RBCCs produced by Compomat® and Optipress®, two currently used top-bottom systems. Results: While the total leukocyte content of the RBCCs was equivalent in both press types (0.5×109), the percentage of mononuclear cells (lymphocytes and monocytes) was significantly higher in the Compomat as compared with the Optipress system (p < 0.0001), resulting in significantly higher numbers of transfused T cells, B cells, HLA-DR-positive cells, NK cells and stem cells. Conclusions: The leukocyte composition of a pre-transplant blood transfusion depends on the BC depletion method used; this might differentially affect the tolerizing or immunizing potential of a pre-transplant blood transfusion.

1.
Opelz G, Vanrenterghem Y, Kirste G, Gray DWR, Horsburg T, Lachance J-G, Largiader F, Lange H, Vujaklija-Stipanovic K, Alvarez-Grande J, Schott W, Hoyer J, Schnuelle P, Descoeudres C, Ruder H, Wujciak T, Schwarz V: Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997;63:964–967.
2.
Reinsmoen NL, Matas AJ, Donaldson L, Carter S: Impact of transfusions and acute rejection on posttransplantation donor antigen-specific responses in two study populations. Cooperative Clinical Trial in Transplantation Research Group. Transplantation 1999;67:697–702.
3.
Persijn GG, Cohen B, Lansbergen Q, van Rood JJ: Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in the Netherlands. Transplantation 1979;28:396–401.
4.
De Wildt-Eggen J, Schrijver JG, Kuiper-Kramer PA, Bins M, van Prooijen HC: Differences in residual white blood cell subset counts in buffy coat-depleted red cell concentrates prepared with bottom and top or quadruple-bag systems. Vox Sang 1999;77:97–102.
5.
Van der Meer PF, Pietersz RNI, Hinloopen B, Dekker WJA, Reesink HW: Automated separation of whole blood in top and bottom bags into components using the Compomat G4. Vox Sang 1999;76:90–99.
6.
Högman CF, Eriksson L, Hedlund K, Wallvik J: The bottom and top system: A new technique for blood component preparation and storage. Vox Sang 1988;55:211–217.
7.
Van Prooijen HC, Aarts-Riemens MI, van Oostendorp WR, Hené RJ, Gmelig-Meyling FHJ, de Weger RA: Prevention of donor-specific T-cell unresponsiveness after buffy-coat-depleted blood transfusion. Br J Haematol 1995;91:219–223.
8.
Vervoordeldonk SF, Doumaid K, Remmerswaal EBM, ten Berge IJM, Wilmink JM, de Waal LP, Boog CJP: Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion. Br J Haematol 1998;102:1004–1009.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.